We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$7.14B
Cap. Flow %
-8.9%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Industrials 9.96%
3 Consumer Discretionary 8.03%
4 Healthcare 7.46%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNQ icon
2976
CALL
Canadian Natural Resources
CNQ
$106B
-24,100
Closed -$1.17M
CNS icon
2977
Cohen & Steers
CNS
$4.19B
-3,572
Closed -$223K
CNTA
2978
DELISTED
Centessa Pharmaceuticals
CNTA
-852,828
Closed -$33.9M
COCO icon
2979
PUT
Vita Coco
COCO
$3.67B
-261,000
Closed -$12.5M
COFS icon
2980
Choiceone Financial
COFS
$496M
-8,675
Closed -$244K
COLL icon
2981
Collegium Pharmaceutical
COLL
$840M
-27,039
Closed -$894K
VISN
2982
PUT
Vistance Networks Inc
VISN
$2.59B
-1,000,000
Closed -$18.2M
COPX icon
2983
CALL
Global X Copper Miners ETF NEW
COPX
$8.76B
-226,500
Closed -$17.3M
COUR icon
2984
Coursera
COUR
$1.59B
-50,391
Closed -$293K
CRBP icon
2985
Corbus Pharmaceuticals
CRBP
$201M
-65,201
Closed -$612K
CRI icon
2986
Carter's
CRI
$1.31B
-1,067,583
Closed -$38.2M
CRNC icon
2987
Cerence
CRNC
$365M
-114,965
Closed -$725K
CROX icon
2988
Crocs
CROX
$5.85B
-3,088
Closed -$337K
CSAN icon
2989
Cosan
CSAN
$2.71B
-44,529
Closed -$183K
CSV icon
2990
Carriage Services
CSV
$547M
-6,819
Closed -$311K
CTGO icon
2991
Contango Silver & Gold Inc
CTGO
$669M
-10,613
Closed -$199K
CTLP
2992
DELISTED
Cantaloupe
CTLP
-1,187,030
Closed -$12.8M
CTLP
2993
PUT
DELISTED
Cantaloupe
CTLP
-1,503,700
Closed -$16.3M
CTMX icon
2994
CytomX Therapeutics
CTMX
$715M
-730,844
Closed -$3.43M
CTRA
2995
CALL
DELISTED
Coterra Energy
CTRA
-1,000,000
Closed -$35.1M
CTRA
2996
DELISTED
Coterra Energy
CTRA
-8,096,749
Closed -$285M
CVGW
2997
PUT
DELISTED
Calavo Growers
CVGW
-317,800
Closed -$8.2M
CVRX icon
2998
CVRx
CVRX
$75.7M
-630,812
Closed -$5.97M
CW icon
2999
Curtiss-Wright
CW
$23.5B
-1,523
Closed -$1.04M
CWAN
3000
CALL
DELISTED
Clearwater Analytics
CWAN
-3,504,900
Closed -$82.9M

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.